[China Net Review] How did China's new crown vaccine win international trust?
China Net commentator Tang Hua
Either out of ideological prejudice, or out of disputes over commercial interests, individual Western media and scholars once tried to slander China's vaccines, and slander statements such as "vaccine diplomacy", "non-transparent data" and "unreliable quality" were rampant.
However, with the influx of overseas orders, leaders of many countries have expressed their trust in China's new crown vaccine in various ways, and malicious attacks have gradually lost the market.
According to media inventory, leaders of at least 10 countries have taken the lead in vaccinating China's new crown vaccine.
Among them, the photo of Indonesian President Joko Widodo vaccinating China's Kexing Company's new crown vaccine on January 13 was also printed on postage stamps as a permanent commemorative.
Believe and dare to trust is trust.
The vaccination of foreign leaders with Chinese vaccines is a demonstration and encouragement to the people of their own countries, and it is also a vote of confidence in China's vaccines.
Trust comes from China's sincerity and goodwill in fulfilling its promises.
"After the research and development of China's new crown vaccine is completed and put into use, it will be used as a global public product to make China's contribution to achieving the accessibility and affordability of the vaccine in developing countries." In May 2020, Chinese President Xi Jinping was in the 73rd session. A solemn promise at the opening ceremony of the World Health Assembly video conference.
In the past year, China has kept its promise and has never stopped providing and assisting the new crown vaccine.
According to the latest news from the Ministry of Foreign Affairs, China has provided or is providing vaccine assistance to 53 countries and exporting vaccines to 27 countries. At the request of the WHO, China has decided to provide 10 million yuan to the "New Coronary Pneumonia Vaccine Implementation Plan" (COVAX). To meet the urgent needs of developing countries, China has also signed vaccine production agreements with many countries to help some countries produce vaccines on their own by exporting vaccine raw materials in order to solve capacity problems and help developing countries reduce costs.
Words must be done, deeds must be resolute, and results must be believed.
China has repeatedly shown to the world with practical actions that China never seeks any geopolitical goals in international cooperation on COVID-19 vaccines, never seeks to obtain any economic benefits, and never attaches any political conditions. It really regards vaccines as a global public product. Contribute China's power to win this fight against the epidemic for all mankind.
Those who treat others with sincerity should be sincere.
The affirmation and trust of all countries in the world for China's vaccines is precisely a positive response to China's courage to assume the responsibilities and obligations of a great power.
Trust comes from the good clinical performance of Chinese vaccines.
The international recognition of products is inseparable from excellent quality.
On December 9th last year, the Emirates News Agency reported that the Phase III clinical trial data of Sinopharm Zhongsheng New Crown Inactivated Vaccine showed that the vaccine is effective to 86% of patients with virus infection, and the neutralizing antibody conversion rate is 99%. The prevention rate of moderate and severe new coronary pneumonia reached 100%.
On December 24, the Turkish Minister of Health Koca held a press conference saying: After the evaluation of the scientific committee, the Turkish side confirmed the effectiveness of the Chinese vaccine in the local test in Turkey.
Preliminary data shows that in the country's Phase III clinical trials, preliminary data show that the effectiveness of the new crown vaccine from China Kexing Company is 91.25%.
On January 7 this year, the government of the State of Sao Paulo, Brazil officially announced the results of the Phase III trial of China's Coxing Vaccine in Brazil.
Data show that the effectiveness of Kexing vaccine is 78%, of which the effectiveness for moderate and severe cases is as high as 100%.
...
Good news has come from countries that have cooperated with Chinese pharmaceutical companies to carry out phase III clinical trials of vaccines. The safety and effectiveness of vaccines in China have exceeded the WHO listing standards, and no serious adverse reactions have occurred.
Therefore, when these countries announced the test data, they also immediately gave the green light for the Chinese vaccine to be launched in their own countries and signed the procurement contract.
The irrefutable test data has made the previous malicious hype about China's vaccine "data opaque" and "unreliable quality" self-defeating. Even the Western media, who have always looked at China with colored glasses in the past, have to admit that Chinese vaccines are important to the world. The contribution of fighting the epidemic cannot be ignored.
The "New York Times" commented that China's vaccines are expected to become "a lifeline for developing countries."
The Associated Press reported that China is one of the few countries that can produce vaccines on a large scale. "For those countries that have not yet obtained vaccines, China may be the only solution."
President Obiang of Equatorial Guinea once said that for many developing countries that lack vaccine development and production capacity, Chinese vaccines are like a timely rain, bringing hope to the local anxious battlefield against the epidemic.
It is believed that this trust will also inspire Chinese pharmaceutical companies to speed up production capacity construction under the premise of ensuring the quality of vaccines, and make unremitting efforts for an early victory in the global epidemic.
(Editor in charge: Li Xiaohua, Qi Yibin, and Cai Xiaojuan)